PI11317 3-((2S,4S)-4-Mercapto-1-(((4-nitrobenzyl)oxy)carbonyl)pyrrolidine-2-carboxamido)benzoic acid (CAS No.: 202467-69-4)

3-[[[(2S,4S)-4-Mercapto-1-(4-nitrobenzyloxy)carbonyl-2-pyrrolidinyl]carbonyl]amino]benzoic acid (CAS No.: 202467-69-4) Description

3-[[[(2S,4S)-4-Mercapto-1-(4-nitrobenzyloxy)carbonyl-2-pyrrolidinyl]carbonyl]amino]benzoic acid is a chemical precursor with a molecular formula of C20H19N3O7S. Its precise reactivity and controlled impurity profile support multi-step pharmaceutical syntheses. The powdered form allows accurate measurement and consistent integration into reaction setups. These properties are critical in facilitating reproducible synthetic routes for complex drug development.

3-[[[(2S,4S)-4-Mercapto-1-(4-nitrobenzyloxy)carbonyl-2-pyrrolidinyl]carbonyl]amino]benzoic acid (CAS No.: 202467-69-4) Applications

Pharmaceutical Research
   - Used as a synthetic precursor in new drug molecule development to achieve higher yield reaction steps by leveraging its controlled reactivity.
   - Applied as an intermediate in the early stages of API synthesis to ensure precision in molecular transformations and impurity control.

Process Development
   - Employed in optimising reaction conditions within multi-step synthesis to attain reproducible impurity profiles by utilising its consistent chemical properties.
   - Used in pilot-scale synthesis to fine-tune reaction parameters for scalability and process reliability.

Chemical Synthesis
   -  Applied as a building block in medicinal chemistry for conjugation reactions to support structure-activity relationship studies by offering defined reactivity.
   - Frequently used in academic research for developing novel synthetic methodologies from well-characterised intermediates.

3-[[[(2S,4S)-4-Mercapto-1-(4-nitrobenzyloxy)carbonyl-2-pyrrolidinyl]carbonyl]amino]benzoic acid (CAS No.: 202467-69-4) Packing

The compound is packaged in moisture-resistant, inert atmosphere packaging within vacuum-sealed, double-layered foil bags that are placed in rigid secondary containers. This method minimises contamination and physical damage during transit. Storage should be in a cool, dry environment under controlled conditions. Custom packaging options, including labelled containers and compartmentalisation, are available to meet specific storage and safety requirements.

Additional Information

Pharmaceutical intermediates are critical components in complex organic synthesis, serving as building blocks for active pharmaceutical ingredients. Their quality and reactivity directly influence the efficiency of subsequent chemical transformations. Detailed analytical characterisation and batch-to-batch consistency are essential to ensure that the intermediates meet the increasingly strict standards of modern pharmaceutical development.

Understanding the underlying chemical properties of these intermediates aids in optimising reaction conditions and scaling up production. Advances in analytical techniques contribute to a more robust assessment of purity and structural integrity, which is vital for achieving reproducible outcomes in both research and commercial manufacturing environments.